Potentially Fatal Adverse Allergic Events to Intravenous Thrombolytics: An Analysis from Adverse Event Reporting System

被引：0
|
作者：
Khan, Asif [1 ]
Zarar, Amna [2 ]
Adil, Malik [3 ]
Qureshi, Adnan [3 ]
机构：
[1] Zeenat Qureshi Stroke Res Ctr, St Louis Pk, MN USA
[2] Zeenat Qureshi Stroke Res Ctr, Minnepolis, MN USA
[3] Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P04078
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Hematological Events Potentially Associated with CDK4/6 Inhibitors: An Analysis from the European Spontaneous Adverse Event Reporting System
    Martins, Vera
    Jesus, Mafalda
    Pereira, Luisa
    Monteiro, Cristina
    Duarte, Ana Paula
    Morgado, Manuel
    [J]. PHARMACEUTICALS, 2023, 16 (10)
  • [32] Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
    Toki T.
    Ono S.
    [J]. Drugs - Real World Outcomes, 2018, 5 (2) : 117 - 128
  • [33] Dalfampridine Associated Serious Adverse Events: An Analysis of Data from the Food and Drug Administration's Adverse Event Reporting System
    Ahmed, Nehad J.
    Alahmari, Abdullah K.
    Alshehri, Ahmed M.
    Almalki, Ziyad S.
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (06): : 1195 - 1199
  • [34] Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
    Jiao, Xue-feng
    Li, Hai-long
    Jiao, Xue-yan
    Guo, Yuan-chao
    Zhang, Chuan
    Yang, Chun-song
    Zeng, Li-nan
    Bo, Zhen-yan
    Chen, Zhe
    Song, Hai-bo
    Zhang, Ling-li
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [35] Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the FDA Adverse Event Reporting System
    Alahmari, Abdullah K.
    Guo, Jeff J.
    Kelton, Christina Ml
    Wigle, Patricia R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 236 - 236
  • [36] Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
    Xue-feng Jiao
    Hai-long Li
    Xue-yan Jiao
    Yuan-chao Guo
    Chuan Zhang
    Chun-song Yang
    Li-nan Zeng
    Zhen-yan Bo
    Zhe Chen
    Hai-bo Song
    Ling-li Zhang
    [J]. Scientific Reports, 10
  • [37] ADVERSE EVENTS ASSOCIATED WITH PEDIATRIC USE OF PROTON PUMP INHIBITORS: ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM
    Alahmari, A. K.
    Guo, J. J.
    Kelton, C. M.
    Wigle, P. R.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A211 - A211
  • [38] Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children Analysis of the Vaccine Adverse Event Reporting System
    Muhammad, Riyadh D.
    Haber, Penina
    Broder, Karen R.
    Leroy, Zanie
    Ball, Robert
    Braun, M. Miles
    Davis, Robert L.
    McMahon, Ann W.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (01) : E1 - E8
  • [39] Adverse Events Associated with Colchicine Drug Interactions: Analysis of the Public Version of the FDA Adverse Event Reporting System
    Almalki, Ziyad S.
    Guo, Jeff J.
    Kelton, Christina M. L.
    Wigle, Patricia R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 83 - 84
  • [40] Ocular adverse events of cenegermin used in neurotrophic keratopathy: an analysis of the FDA adverse event reporting system database
    Li, Yunfei
    Yang, Haiyun
    Gao, Yuan
    He, Weimin
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024, 23 (03) : 385 - 391
12345